Covalon Technologies Ltd V.COV

Alternate Symbol(s): CVALF

Healthcare Medical Instruments & Supplies

Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon's name, and by developing and commercializing medical products for other medical companies under development and license contracts. The Company has three proprietary platform technologies that have the potential to be developed into a number of medical devices and products: Collagen matrix, Antimicrobial silicone adhesive and Medical coatings. Its product type includes advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, and perioperative dressings. Its brands include ColActive PLUS, CovaClear, CovaView, CovaWound, IV Clear, SurgiClear, and VALGuard.

TSXV:COV - Post by User

Covalon Technologies Ltd > cov Research Capital launches coverage of Covalon with a “Bu

<< Previous

Bullboard Posts

Next >>

Comment by ValueGuy1965on Dec 06, 2024 1:39pm

69 Views

Post# 36349671

RE:cov Research Capital launches coverage of Covalon with a “Bu

I am not sure this is accurate as the report indicates EPS of $0.13 in 2024 in the detailed spreadsheet not break even.

"Uddin thinks COV will break even EPS on revenue of $32.0-million in fiscal 2024. He expects those numbers will improve to EPS of $0.04 on a topline of $36.0-million in fiscal 2025. "

<< Previous

Bullboard Posts

Next >>

Three business reasons companies need to recycle e-waste